The Institute for Biological Research will begin the human trials phase of its coronavirus vaccine this coming Sunday. The human trials will last several months, and will include three phases. In the first phase initial safety checks on 80 volunteers will be conducted, in the second phase there will be safety tests on 960 volunteers, and in the third phase safety tests will be conducted on 30 thousand volunteers.